Acadian Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $404K | Buy |
|
|||||
|
2025
Q1 | $337K | Buy |
|
|||||
|
2024
Q4 | $364K | Sell |
|
|||||
|
2024
Q3 | $2.18M | Buy |
|
|||||
|
2024
Q2 | $571K | Buy |
|
|||||
|
2024
Q1 | $478K | Sell |
|
|||||
|
2023
Q4 | $4.11M | Sell |
|
|||||
|
2023
Q3 | $5.26M | Buy |
|
|||||
|
2023
Q2 | $2.26M | Sell |
|
|||||
|
2023
Q1 | $10.9M | Buy |
|
|||||
|
2022
Q4 | $6.36M | Buy |
|
|||||
|
2022
Q3 | $3.51M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $27K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $151K | Sell |
|
|||||
|
2021
Q1 | $447K | Buy |
|
|||||
|
2020
Q4 | $94K | Sell |
|
|||||
|
2020
Q3 | $1.08M | Buy |
|
|||||
|
2020
Q2 | $964K | Buy |
|
|||||
|
2020
Q1 | $98K | Buy |
|
|||||
|
2019
Q4 | $48K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $8K | Sell |
|
|||||
|
2018
Q4 | $32K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $8K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $8K | Buy |
|